- Research Article
- Open Access
Proteomic analysis of tumor tissue in CT-26 implanted BALB/C mouse after treatment with ascorbic acid
Cellular & Molecular Biology Letters volume 17, pages62–76(2012)
Tumor establishment and penetration consists of a series of complex processes involving multiple changes in gene expression and protein modification. Proteome changes of tumor tissue were investigated after intraperitoneal administration of a high concentration of ascorbic acid in BALB/C mice implanted with CT-26 cancer cells using two-dimensional gel electrophoresis and mass spectrometry. Eighteen protein spots were identified whose expression was different between control and ascorbic acid treatment groups. In particular, eukaryotic translation initiation factor 3 subunit 1, nucleophosmin, latexin, actin-related protein 2/3 complex subunit 5, M2-type pyruvate kinase, vimentin, tumor protein translationally-controlled 1, RAS oncogene family Ran, plastin 3 precursor, ATPase, Rho GDT dissociation inhibitor β, and proteasome activator subunit 2 expression were quantitatively up-regulated. The increase in the level of these proteins was accompanied by an increase in mRNA level. The cytoskeleton protein actin, vimentin, and tumor protein translationally-controlled 1 showed quantitative expression profile differences. A change in actin cytoskeleton distribution, functionally relevant to the proteome result, was observed after treatment with ascorbic acid. These results suggest a previously undefined role of ascorbic acid in the regulation of cytoskeleton remodeling in tumor tissues.
- MALDI TOF-MS/MS:
Matrix-assisted laser-desorption ionization time-of-flight tandem mass spectroscopy
polyacrylamide gel electrophoresis
phosphate buffered solution
polymerase chain reaction
sodium dodecyl sulfate
translationally controlled tumor protein
two-dimensional gel electrophoresis
Padayatty, S.J., Sun, H., Wang, Y., Riordan, H.D., Hewitt, S.M., Katz, A., Wesley, R.A. and Levine, M. Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann. Intern. Med. 140 (2004) 533–537.
Bram, S., Froussard, P., Guichard, M., Jasmin, C., Augery, Y., Sinoussi-Barre, F. and Wray, W. Ascorbic acid preferential toxicity for malignant melanoma cells. Nature 284 (1980) 629–631.
Bruchelt, G., Baader, L., Reith, A.G., Holger, N.L., Gebhardt, S. and Niethammer, D. Rationale for the use of ascorbic acid in neuroblastoma therapy. Human Neuroblastoma Newark: Harwood Academic Publishers (1993) 34–40.
Fujinaga, S., Sakagami, H., Kuribayashi, N., Takayama, H., Amano, Y., Sakagami, T. and Takeda, M. Possible role of hydrogen peroxide in apoptosis induction by ascorbic acid in human myelogenous leukemic cell lines. Showa University Journal of Medical Sciences 6 (1994) 135–144.
De Laurenzi, V., Melino, G., Savini, I., Annicchiarico-Petruzzelli, M., Finazzi-Agro, A. and Avigliano, L. Cell death by oxidative stress and ascorbic acid regeneration in human neuroectodermal cell lines. Eur. J. Cancer 31A (1995) 463–466.
Park, C.H. Biological nature of the effect of ascorbic acids on the growth of human leukemic cells. Cancer Res. 45 (1985) 3969–3973.
Park, C.H., Kimler, B.F., Bodensteiner, D., Lynch, S.R. and Hassanein, R.S. In vitro growth modulation by L-ascorbic acid of colony-forming cells from bone marrow of patients with myelodysplastic syndromes. Cancer Res. 52 (1992) 4458–4466.
Park, S., Han, S.S., Park, C.H., Hahm, E.R., Lee, S.J., Park, H.K., Lee, S.H., Kim, W.S., Jung, C.W., Park, K., Riordan, H.D., Kimler, B.F., Kim, K. and Lee, J.H. L-Ascorbic acid induces apoptosis in acute myeloid leukemia cells via hydrogen peroxidemediated mechanisms. Int. J. Biochem. Cell. Biol. 36 (2004) 2180–2195.
Fidler, I.J. Critical determinants of cancer metastasis: rationale for therapy. Cancer Chemother. Pharmacol. 43 (1999) S3–S10.
Mignatti, P. and Rifkin, D.B. Biology and biochemistry of proteinases in tumor invasion. Physiol. Rev. 73 (1993) 161–195.
Rath, M. and Pauling, L. Plasmin-induced proteolysis and the role of apoprotein(a), lysine and synthetic analogs. J. Orthomolecular Med. 7 (1992) 17–23.
Roomi, M.W., Roomi, N.W., Ivanov, V., Kalinovsky, T., Niedzwiecki, A. and Rath, M. Modulation of N-methyl-N-nitrosourea induced mammary tumors in Sprague-Dawley rats by combination of lysine, proline, arginine, ascorbic acid and green tea extract. Breast Cancer Res. 7 (2005) R291–R295.
Kohn, E.C. Development and prevention of metastasis. Anticancer Res. 13 (1993) 2553–2559.
Wybieralska, E., Koza, M., Sroka, J., Czyz, J. and Madeja, Z. Ascorbic acid inhibits the migration of Walker 256 carcinosarcoma cells. Cell. Mol. Biol. Lett. 13 (2008) 103–111.
Meadows, G.G., Pierson, H.F. and Abdallah, R.M. Ascorbate in the treatment of experimental transplanted melanoma. Am. J. Clin. Nutrit. 54 (1991) 1284S–1291S.
Taper, H.S., Jamison, J.M., Gilloteaux, J., Summers, J.L. and Calderon, P.B. Inhibition of the development of metastases by dietary vitamin C:K3 combination. Life Sci. 75 (2004) 955–967.
Taper, H.S., Jamison, J.M., Gilloteaux, J., Gwin, C.A., Gordon, T., and Summers, J.L. In vivo reactivation of DNases in implanted human prostate tumors after administration of a vitamin C/K3. J. Histochem. Cytochem. 49 (2001) 109–119.
Skalli, O., Ropraz, P., Trzeciak, A., Benzonana, G., Gillessen, D. and Gabbiani, G. A monoclonal antibody against α-smooth muscle actin: A new probe for smooth muscle differentiation. J. Cell Biol. 103 (1986) 2787–2796.
Van Muijen, G.N.P., Ruiter, D.J. and Warnaar, S.O. Coexpression of intermediate filament polypeptides in human fetal and adult tissues. Lab. Invest. 57 (1987) 359–369.
Goddard, M.J., Wilson, B. and Grant, J.W. Comparison of commercially available cytokeratin antibodies in normal and neoplastic adult epithelial and non-epithelial tissues. J. Clin. Pathol. 44 (1991) 660–663.
Kobayashi, N. and Mundel, P. A role of microtubules during the formation of cell processes in neuronal and non-neuronal cells. Cell Tissue Res. 91 (1998) 163–174.
Duncan, J.E. and Warrior, R. The cytoplasmic dynein and kinesin motors have interdepedent roles in pattering the Drosophila oocyte. Curr. Biol. 12 (2002) 1982–1991.
Lechner, A., Leech, C.A., Abraham, E.J., Nolan, A.L. and Habener, J.F. Nestin-positive progenitor cells derived from adult human pancreatic islets of Langerhans contain side population (SP) cells defined by expression of the ABCG2 (BCRP1) ATP-binding cassette transporter. Biochem. Biophys. Res. Commun. 293 (2002) 670–674.
Yang, S.H., Kim, J.S., Oh, T.J., Kim, M.S., Lee, S.W., Woo, S.K., Cho, H.S., Choi, Y.H., Kim, Y.H., Rha, S.Y., Chung, HC. and An, S.W. Genome-scale analysis of resveratrol-induced gene expression profile in human ovarian cancer cells using a cDNA microarray. Int. J. Oncol. 22 (2003) 741–750.
Gruber, H.E., Tewfik, H.H. and Tewfik, F.A. Cytoarchitecture of Ehrlich ascites carcinoma implanted in the hind limb of ascorbic acid-supplemented mice. Eur. J. Cancer. 16 (1980) 441–448.
Bommer, U.A. and Thiele, B.J. The translationally controlled tumor protein (TCTP). Int. J. Biochem. Cell. Biol. 36 (2004) 379–385.
Bommer, U.A., Borovjagin, A.V., Greagg, M.A., Jeffrey, I.W., Russell, P., Laing, K.G., Lee, M. and Clemens, M.J. The mRNA of the translationally controlled tumor protein P23/TCTP is a highly structured RNA, which activates the dsRNA-dependent protein kinase PKR. RNA 8 (2002) 478–496.
Nielsen, H.V., Johnsen, A.H., Sanchez, J.C., Hochstrasser, D.F. and Schiotz, P.O. Identification of a basophil leukocyte interleukin-3-regulated protein that is identical to IgE-dependent histamine-releasing factor. Allergy 53 (1998) 642–652.
Teshima, S., Rokutan, K., Nikawa, T. and Kishi, K. Macrophage colonystimulating factor stimulates synthesis and secretion of a mouse homolog of a human IgE-dependent histamine-releasing factor by macrophages in vitro and in vivo. J. Immunol. 161 (1998) 6356–6366.
Thiele, H., Berger, M., Skalweit, A. and Thiele, B.J. Expression of the gene and processed pseudogenes encoding the human and rabbit translationally controlled tumor protein (TCTP). Eur. J. Biochem. 267 (2000) 5473–5481.
Gachet, Y., Tournier, S., Lee, M., Lazaris-Karatzas, A., Poulton, T. and Bommer, U.A. The growth-related, translationally controlled protein P23 has properties of a tubulin binding protein and associates transiently with microtubules during the cell cycle. J. Cell. Sci. 112 (1999) 1257–1271.
Yarm, F.R. Plk phosphorylation regulates the microtubule-stabilizing protein TCTP. Mol. Cell. Biol. 22 (2002) 6209–6221.
Yoon, T., Jung, J., Kim, M., Lee, K.M., Choi, E.C. and Lee, K. Identification of the self-interaction of rat TCTP/IgE-dependent histamine-releasing factor using yeast two-hybrid system. Arch. Biochem. Biophys. 384 (2000) 379–382.
Sinha, P., Kohl, S., Fischer, J., Hütter, G., Kern, M., Köttgen, E., Dietel, M., Lage, H., Schnölzer, M. and Schadendorf, D. Identification of novel proteins associated with the development of chemoresistance in malignant melanoma using two-dimensional electrophoresis. Electrophoresis 21 (2000) 3048–3057.
Walker, D.J., Pitsch, J.L., Peng, M.M., Robinson, B.L., Peters, W., Bhisutthibhan, J. and Meshnick, S.R. Mechanisms of artemisinin resistance in the rodent malaria pathogen Plasmodium yoelii. Antimicrob. Agents Chemother. 44 (2000) 344–347.
Thaw, P., Baxter, N.J., Hounslow, A.M., Price, C., Waltho, J.P. and Craven, C.J. Structure of TCTP reveals unexpected relationship with guanine nucleotide-free chaperones. Nat. Struct. Biol. 8 (2001) 701–704.
Li, F., Zhang, D. and Fujise, K. Characterization of fortilin, a novel antiapoptotic protein. J. Biol. Chem. 276 (2001) 47542–47549.
Tuynder, M., Susini, L., Prieur, S., Besse, S., Fiucci, G., Amson, R. and Telerman, A. Biological models and genes of tumor reversion: Cellular reprogramming through tpt1/TCTP and SIAH-1. Proc. Natl. Acad. Sci. USA 99 (2002) 14976–14981.
About this article
Cite this article
Lee, J., Lee, G., Park, J.H. et al. Proteomic analysis of tumor tissue in CT-26 implanted BALB/C mouse after treatment with ascorbic acid. Cell Mol Biol Lett 17, 62–76 (2012). https://doi.org/10.2478/s11658-011-0035-7
- Cytoskeleton remodelling
- Ascorbic acid
- Tumor tissue